Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Non-Current Assets (2020 - 2025)

Definitive Healthcare (DH) has disclosed Non-Current Assets for 6 consecutive years, with $477.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets rose 12505.83% year-over-year to $477.9 million, compared with a TTM value of $2.0 billion through Dec 2025, up 53797.73%, and an annual FY2025 reading of $477.9 million, up 12505.83% over the prior year.
  • Non-Current Assets was $477.9 million for Q4 2025 at Definitive Healthcare, down from $509.2 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.7 billion in Q2 2022 and bottomed at $3.8 million in Q4 2024.
  • Average Non-Current Assets over 5 years is $804.5 million, with a median of $535.2 million recorded in 2025.
  • The sharpest move saw Non-Current Assets crashed 99.7% in 2021, then surged 35088.36% in 2023.
  • Year by year, Non-Current Assets stood at $5.1 million in 2021, then decreased by 11.94% to $4.5 million in 2022, then grew by 0.16% to $4.5 million in 2023, then fell by 15.21% to $3.8 million in 2024, then skyrocketed by 12505.83% to $477.9 million in 2025.
  • Business Quant data shows Non-Current Assets for DH at $477.9 million in Q4 2025, $509.2 million in Q3 2025, and $521.0 million in Q2 2025.